The serum CgA level increases with the progression of type 1 diabetes, and it is associated with the development of enterochromaffin-like cell hyperplasia and autoimmune gastritis [8], from which neuroendocrine tumors can arise [17, 18]. The gene discussed is CGA; the disease is neuroendocrine neoplasm.